171 related articles for article (PubMed ID: 31190124)
1. Time-to-Interventional Failure as a New Surrogate Measure for Survival Outcomes after Resection of Hepatocellular Carcinoma.
Shindoh J; Kawamura Y; Kobayashi Y; Akuta N; Kobayashi M; Suzuki Y; Ikeda K; Hashimoto M
J Gastrointest Surg; 2020 Jan; 24(1):50-57. PubMed ID: 31190124
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
3. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
6. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection.
Park S; Choi S; Cho YA; Sinn DH; Kim JM; Park CK; Ha SY
Cancer Res Treat; 2020 Oct; 52(4):1145-1152. PubMed ID: 32599989
[TBL] [Abstract][Full Text] [Related]
8. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.
Zhang H; Yuan SX; Dai SY; Zhang JM; Huang X; Lu CD; Lu JH; Wu FQ; Lau WY; Wu MC; Yang T; Shen F
World J Surg; 2014 Apr; 38(4):947-57. PubMed ID: 24258262
[TBL] [Abstract][Full Text] [Related]
9. Recurrent hepatocellular carcinoma: a Western strategy that emphasizes the impact of pathologic profile of the first resection.
Meniconi RL; Komatsu S; Perdigao F; Boëlle PY; Soubrane O; Scatton O
Surgery; 2015 Mar; 157(3):454-62. PubMed ID: 25633732
[TBL] [Abstract][Full Text] [Related]
10. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcomes of recurrent hepatocellular carcinomas.
Joliat GR; Allemann P; Labgaa I; Demartines N; Halkic N
Langenbecks Arch Surg; 2017 Aug; 402(5):737-744. PubMed ID: 28497194
[TBL] [Abstract][Full Text] [Related]
12. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 2 curative treatment options for very early hepatocellular carcinoma: Efficacy, recurrence pattern, and retreatment.
Kim TH; Chang JM; Um SH; Jee H; Lee YR; Lee HA; Yim SY; Han NY; Lee JM; Choi HS; Kim ES; Yu YD; Keum B; Kim MJ; An H; Park BJ; Seo YS; Kim DS; Yim HJ; Cho SB; Jeen YT; Lee HS; Chun HJ; Kim YH; Kim CD
Medicine (Baltimore); 2019 Jun; 98(26):e16279. PubMed ID: 31261600
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma.
Shah SA; Wei AC; Cleary SP; Yang I; McGilvray ID; Gallinger S; Grant DR; Greig PD
J Gastrointest Surg; 2007 May; 11(5):589-95. PubMed ID: 17393258
[TBL] [Abstract][Full Text] [Related]
15. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
[TBL] [Abstract][Full Text] [Related]
17. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.
Chan AC; Poon RT; Cheung TT; Chok KS; Chan SC; Fan ST; Lo CM
World J Surg; 2012 Jan; 36(1):151-6. PubMed ID: 22030561
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
19. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
[TBL] [Abstract][Full Text] [Related]
20. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
